HomeGeneticsConditionOptic atrophy type 1
Back to Condition
Optic atrophy type 1
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Optic Atrophy Type 1

Optic atrophy type 1 is an inherited eye condition characterized by a progressive loss of vision, tunnel vision, and color vision deficiencies that typically begin in childhood.

Overview

Optic atrophy type 1 is a condition that often causes slowly worsening vision, usually beginning in childhood. Both eyes are typically affected equally, but the severity of the vision loss varies widely, even among affected members of the same family, ranging from nearly normal vision to complete blindness.

Symptoms & Clinical Features

People with this condition experience a progressive decline in visual function, which is characterized by several distinct features:

  • Tunnel vision: Affected individuals typically experience a narrowing of their field of vision. They gradually lose their sight as their field of vision becomes smaller.
  • Color vision deficiency: In addition to vision loss, affected individuals frequently have problems with color vision that make it difficult or impossible to distinguish between shades of blue and green.
  • Retinal cell loss: In the early stages of the condition, individuals experience a progressive loss of retinal ganglion cells, which are specialized light-sensitive cells within the retina at the back of the eye.
  • Optic nerve degeneration: The loss of retinal ganglion cells is followed by the degeneration (atrophy) of the optic nerves, which relay visual information from the eye to the brain.
  • Optic nerve pallor: Atrophy causes these nerves to have an abnormally pale appearance (pallor), which can be observed during an eye examination.

Frequency

Optic atrophy type 1 is estimated to affect 1 in 35,000 people worldwide. This condition is more common in Denmark, where it affects approximately 1 in 10,000 people.

Causes & Genetics

Optic atrophy type 1 is caused by mutations in the OPA1 gene. The protein produced from this gene is active in cells and tissues throughout the body and is located within the mitochondria, the energy-producing centers of cells.

The OPA1 protein plays a key role in:

  • Organizing the shape and structure of the mitochondria.
  • Regulating controlled cell death (apoptosis).
  • Supporting oxidative phosphorylation, the process by which cells derive much of their energy.
  • Maintaining mitochondrial DNA (mtDNA).

Mutations in the OPA1 gene lead to poorly functioning, misshapen, and disorganized mitochondria with reduced energy-producing capabilities. Cells with high energy demands, such as retinal ganglion cells, become highly susceptible to apoptosis and die over time. Because the specialized extensions (axons) of these cells form the optic nerves, the death of retinal ganglion cells leads to optic nerve atrophy and the loss of visual transmission to the brain.

Inheritance Pattern

This condition is inherited in an autosomal dominant pattern, meaning one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person inherits the mutation from an affected parent. Other cases result from new mutations and occur in people with no history of the disorder in their family. In rare cases, individuals with an OPA1 gene mutation do not develop the condition, a phenomenon known as reduced penetrance.

Other Names for This Condition

  • ADOA
  • Autosomal dominant optic atrophy
  • Autosomal dominant optic atrophy Kjer type
  • DOA
  • Dominant optic atrophy
  • Kjer type optic atrophy
  • Kjer's optic atrophy
  • Optic atrophy, autosomal dominant
  • Optic atrophy, hereditary, autosomal dominant
  • Optic atrophy, juvenile
  • Optic atrophy, Kjer type

Frequently Asked Questions

The diagnosis is made through a combination of a detailed visual field test (to detect tunnel vision), color vision testing, and a dilated fundus examination that reveals a pale optic disc. Optical coherence tomography (OCT) can measure thinning of the retinal nerve fiber layer, and genetic testing for known mitochondrial or nuclear gene mutations may confirm the diagnosis.
Because optic atrophy type 1 is inherited, families can undergo targeted genetic testing to identify the specific mutation. Genetic counselors can explain recurrence risks, discuss options for prenatal testing or preimplantation genetic diagnosis, and provide resources for support groups. Early identification of carriers helps families plan and seek early interventions for affected children.===
Parents often notice that a child has trouble seeing objects far away or in peripheral vision, especially when playing sports or reading. The child may also complain of difficulty distinguishing colors, particularly blues and greens, and may have trouble navigating in low light. These subtle changes can appear as early as the first few years of life and warrant an eye exam.
Currently there is no cure that stops the progression of optic atrophy type 1. However, low‑vision aids, such as magnifiers, high‑contrast visual aids, and adaptive lighting, can help maintain independence. Some patients benefit from vitamin B12 or coenzyme Q10 supplementation, but evidence is limited. Regular monitoring by an ophthalmologist is essential to adjust support as vision changes.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA